Chin Y, Plessers L, Vandepitte J, Raus J
Department of Immunology, Dr L. Willems Instituut, Diepenbeek, Belgium.
Eur J Cancer. 1991;27(1):48-50. doi: 10.1016/0277-5379(91)90059-m.
A murine monoclonal antibody, 5D10, raised against the human breast cancer cell line MCF7 reacted preferably with mammary carcinomas and weakly with normal epithelial cells. The antigens recognised by the antibody had molecular weights of about 28 and 90 kD. The reactivity of the antibody to human breast carcinomas correlated with the DNA ploidy status of the tumour cells. Upon analysis of 54 breast carcinoma specimens, the percentage of antibody positive cells was significantly higher in tumours with an aneuploid stemline than in those with a diploid DNA content (P less than 0.001). This antibody therefore could be a useful tool in evaluating the prognosis of breast carcinomas.
一种针对人乳腺癌细胞系MCF7产生的鼠单克隆抗体5D10,与乳腺癌的反应性较好,与正常上皮细胞的反应性较弱。该抗体识别的抗原分子量约为28和90 kD。该抗体对人乳腺癌的反应性与肿瘤细胞的DNA倍体状态相关。在对54例乳腺癌标本进行分析时,非整倍体主干线肿瘤中抗体阳性细胞的百分比显著高于DNA含量为二倍体的肿瘤(P小于0.001)。因此,该抗体可能是评估乳腺癌预后的有用工具。